No Detail Found!

The effects of TPL-PEI-CyD on suppressing performance of MCF-7 stem cells

Author(s)
Yimin Zhu The First Affiliated Hospital of Lishui University / College of Medicine and Health, Lishui University,Lishui,China
Fuying Xu The First Affiliated Hospital of Lishui University / College of Medicine and Health, Lishui University,Lishui,China
Abstract
Triptolide, an ingredient of Tripterygium wilfordii, has been demonstrated to possess many biological activities such as immunomodulatory, antitumor activity in experiment. The purpose of this study was to survey the toxicity of TPL-PEI-CyD on renal cells and its effects on breast carcinoma stem cells. The cytotoxicity of TPL-PEI-CyD and TPL on HK-2 was comparatively assessed by CCK-8. After incubation and culturing with TGF-ß1, the MCF-7 cells were assessed by flow cytometry for the proportion of CD44+ CD24- cells; then the CD44+ CD24- cells were sorted by immunomagnetic beads as MCF-7 stem cells. To assess the effect of TPL-PEI-CyD on MCF-7 stem cells, Western Blot was used to detect the expression of Oct-4 and ALDHl in MCF-7 stem cells after being dosed with TPL- PEI-CyD. Results showed that, compared with TPL, the toxicity of TPL-PEI-CyD on HK-2 cells was significantly reduced (P<0.05). Breast carcinoma stem cells can be enriched by TGF-ß1 and isolated from MCF-7 cells by immunomagnetic sorting. TPL- PEI-CyD can even more significantly suppress the expression of Oct-4 and ALDHA1 in MCF-7 stem cells than TPL (P<0.05). In conclusion, after coupling TPL and PEI-CyD, TPL-PEI-CyD showed characteristics of effective suppression to breast carcinoma stem cell and decrease of cytotoxicity. It presented the unique effect of traditional Chinese medicine as an efficient and low toxic drug carrier complex for breast carcinoma treatment.
Publication Details
Page(s) 835-838
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 33, Issue: SUP2, Year: 2020

Request the full text from PASTIC

Keywords
Triptolide, breast carcinoma, tumor stem cell
References
Chen JX,Qiao YT,Tang B .2017 .Modulation of salmonella tumor-colonization and intratumoral antiangiogenesis by triptolide and tts mechanism. , 7(8) : 2250-2260.
Chen NN,Bi YK .2019 .Effects of triptolide on inflammatory related factors induced by LPS in mouse peritoneal macrophages. Chin. Rural Health, 11(22) : 23-24.
Gadde S .2015 .Multi-drug delivery nanocarriers for combination therapy. Med, 6(11) : 1916-1929.
Li W,Chen AH,Que HQ,Quo SM,Lin S .2019 .Research progress on triptolide structural modification and structure-activity relationship. Drug. Eval. Res., 42(8) : 1651-1662.
Liang EY,He M .2019 .Research progress in the immune regulation mechanisms of Triptolide. Pract. J. Clin. Med, 16(1) : 234-237.
Lin CC,Chi B,Wong K,Chen HB K .2017 .Pulmonary delivery of triptolideloaded liposomes decorated with anti-carbonic anhydrase IX antibody for lung cancer therapy. Sci. Rep, 7(1) : 1097-1108.
Liu C and Zhang Z .2017 .Synthesis of kidney-targeted prodrug triptolide-glucosamine conjugate. , 32(5) : 452-455.
Liu N,Liu M. Y,Li Y M. Y .2015 .Research Progress of Triptolide in vitro and in vivo. Strait Pharm. J., 27(12) : 99-101.
Sun L,Zhao JL,Lan X,Lv ZQ,Li Y,Li WW Y .2019 .Effects and mechanism of triptolide on myeloid derived suppressor cells in lung cancer-bearing mice. Zhejiang Med, 41(22) : 2379-2383.
Wu B,Lu ST,Zhang LJ,Zhu RX .2017 .Codelivery of doxorubicin and triptolide with reduction-sensitive lipid-polymer hybrid nanoparticles for in vitro and in vivo synergistic cancer treatment. Int. J. Nanomedicine, 12(1) : 1853-1862.
Zai XJ,Zhang H,Zhang YN H .2016 .Relationship between cell activity and multidrug resistance of CD44+ CD24- /low breast cancer stem cells. J. Clin. Rehabil. Tissue Eng. Res., 20(32) : 4758-4763.
0

Citations

0

Downloads

15

Views